Advances in Biopharmaceutical Technology in China
back to index

 

Chapter 17:   Organizations in China involved in Biopharmaceutical Research and Manufacturing

By Eliza Yibing Zhou

About the Author:
Yibing (Eliza) Zhou, Project Director. Ms. Zhou holds a Bachelor of Pharmaceutical Chemistry (1987) from the West China University of Medical Sciences (merged into Sichuan University in 2001). She also had five-years of supervisory experience at the Sun Yat-sen University-affiliated hospital pharmacy. Ms. Zhou is an experienced Chinese pharmaceutical technical information researcher, consultant and translator of technical and scientific matters. Her expertise focuses in two areas: consultation on the biopharmaceutical industry and hospital pharmacy in China, and Chinese biomedical literature research and translation. She also has more than 12 years' experience working as a Marketing Manager and Product Manager at various Chinese-owned and foreign joint-venture pharmaceutical companies, including the South-West China Pharmaceutical Co., Willine Pharmaceutical Co., AstraZeneca (Guangzhou Branch) and other pharmaceutical companies.

Abstract:
China is projected to become one of the world's major biotech players in the next 15 years. The country's biopharmaceutical industry has witnessed rapid growth since the late 1980s and is continuing to grow soundly with more than 30 percent annual revenue growth. Its gross biopharmaceutical revenue exceeded 20 billion RMB (US$2.5 billion) in 2003 and quickly achieved 30 billion RMB (US$3.7 billion) in 2005. Such a rapid growth reflects, among other factors, the government's efforts to keep biotech and biopharmaceutical high on the agenda. The number of organizations involved in biopharmaceutical research and manufacturing in China has also shown an increase. Today, there are more than 400 biotech research institutions in China, among which 300 institutions are focused on biotech drug development. Since 1989 when the first modern biopharmaceutical company was founded, a growing number of biopharmaceutical companies have been established solidly in China. By the end of 2005, there have been 400 biopharmaceutical manufacturers established in China. China's most competitive edge lies in low development and manufacturing cost. Over the past few decades, an increasing number of global biopharmaceutical companies or contract research organizations (CROs) have set up subsidiaries, factories or research centers in China. This chapter provides the following:

  • General introduction to the institutions and companies involved in biopharmaceutical research and manufacturing in China.
  • Major biotech research institutions, biopharmaceutical manufactures and pharmaceutical distributors are profiled.
  • Government administrative institutions concerned with biotechnology and the biopharmaceutical industry are also described.
  • The chapter is aimed at providing detailed information for overseas biotech research institutions, CROs, universities with life sciences or biotech majors, or biopharmaceutical companies who are interested in seeking business opportunities in China.
back to index
Eric Langer
BioPlan Associates, Inc.
2275 Research Blvd, Suite 500
Rockville, MD 20850
Phone: 301-921-5979; Fax: 301-926-2455
E-Mail: info@bioplanassociates.com